Expertise in
3
conditions

Lieven Maene

OnzeLieveVrouwziekenhuis Aalst
Aalst, VLG, BE 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
3
conditions
OnzeLieveVrouwziekenhuis Aalst
Aalst, VLG, BE 

Overview

Lieven Maene practices practicing medicine in Aalst, Belgium.

Maene is highly rated in 3 conditions, according to our data. Their clinical expertise encompasses Peripheral Artery Disease, Atherosclerosis, Thoracic Outlet Syndrome, Abdominal Aortic Aneurysm (AAA), and Angioplasty.

They are actively involved in clinical research, co-authoring 32 peer reviewed articles and participating in 18 clinical trials.

Locations

OnzeLieveVrouwziekenhuis Aalst
Aalst, VLG, Belgium
Other Locations
ZNA Stuivenberg
Antwerpen, VLG, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

18 Clinical Trials

An RCT Evaluating the Safety and Efficacy of the Endovascular Treatment of Subjects with Stenotic or Restenotic Lesions of the Common Femoral Artery with the Supera Vascular Mimetic Implant Compared to Surgical Common Femoral Artery Endarterectomy
An RCT Evaluating the Safety and Efficacy of the Endovascular Treatment of Subjects with Stenotic or Restenotic Lesions of the Common Femoral Artery with the Supera Vascular Mimetic Implant Compared to Surgical Common Femoral Artery Endarterectomy
Enrollment Status: Recruiting
Publish Date: October 16, 2024
Intervention Type: Device, Procedure
Study Phase: Not Applicable
Belgian Physician-initiated Trial Investigating the LifeStream Peripheral Stent Graft System for the Treatment of Complex TASC C and D Iliac Lesions
Belgian Physician-initiated Trial Investigating the LifeStream Peripheral Stent Graft System for the Treatment of Complex TASC C and D Iliac Lesions
Enrollment Status: Completed
Publish Date: March 05, 2026
Intervention Type: Device
Study Phase: Not Applicable
Stellarex Vascular E-Registry
Stellarex Vascular E-Registry
Enrollment Status: Completed
Publish Date: August 14, 2025
Intervention Type: Device
A Prospective, Multicentre Observational Study to Evaluate the BioMimics 3D Self-Expanding Stent System in the Treatment of Peripheral Arterial Disease: MIMICS-3D
A Prospective, Multicentre Observational Study to Evaluate the BioMimics 3D Self-Expanding Stent System in the Treatment of Peripheral Arterial Disease: MIMICS-3D
Enrollment Status: Completed
Publish Date: April 17, 2025
Intervention Type: Device
Randomized & Controlled Noninferiority Trial to Evaluate Safety & Clinical Efficacy of SurVeil™ Drug-Coated Balloon (DCB) iN Treatment of Subjects With Stenotic Lesions of Femoropopliteal Artery Compared to Medtronic IN.PACT® Admiral® DCB
Randomized & Controlled Noninferiority Trial to Evaluate Safety & Clinical Efficacy of SurVeil™ Drug-Coated Balloon (DCB) iN Treatment of Subjects With Stenotic Lesions of Femoropopliteal Artery Compared to Medtronic IN.PACT® Admiral® DCB
Enrollment Status: Completed
Publish Date: March 25, 2025
Intervention Type: Device
Study Phase: Not Applicable
Physician Initiated, Prospective, Non-randomized Belgian Multi-center Trial, Investigating the Safety and Efficacy of the Treatment With the LumINor DCB and The IvolutioN Stent of iVascular in TASC C and D Femoropopliteal Atherosclerotic Disease
Physician Initiated, Prospective, Non-randomized Belgian Multi-center Trial, Investigating the Safety and Efficacy of the Treatment With the LumINor DCB and The IvolutioN Stent of iVascular in TASC C and D Femoropopliteal Atherosclerotic Disease
Enrollment Status: Completed
Publish Date: March 06, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Randomized Trial Comparing the ELUVIA Drug-eluting Stent Versus Bare Metal Self-expanding Nitinol Stents in the Treatment of Superficial Femoral and/or Proximal Popliteal Arteries
A Randomized Trial Comparing the ELUVIA Drug-eluting Stent Versus Bare Metal Self-expanding Nitinol Stents in the Treatment of Superficial Femoral and/or Proximal Popliteal Arteries
Enrollment Status: Completed
Publish Date: February 24, 2025
Intervention Type: Device
Study Phase: Not Applicable
Belgian-Italian Prospective, Single Arm, Multicentre Study to Evaluate the Efficacy and Safety of BTK Treatment With the Luminor 14 Paclitaxel Coated Percutaneous Transluminal Angioplasty Balloon Catheter of iVascular of 150 Subjects With Critical Limb Ischemia
Belgian-Italian Prospective, Single Arm, Multicentre Study to Evaluate the Efficacy and Safety of BTK Treatment With the Luminor 14 Paclitaxel Coated Percutaneous Transluminal Angioplasty Balloon Catheter of iVascular of 150 Subjects With Critical Limb Ischemia
Enrollment Status: Completed
Publish Date: November 08, 2024
Intervention Type: Device
Study Phase: Not Applicable
Belgian Prospective, Non-randomized Multi-center, Controlled Physician-initiated Trial: Evaluation of the Safety and Efficacy of the ClearLumen II Peripheral Thrombectomy System Recanalization of Acute and Subacute Thrombotic Femoropopliteal Occlusions
Belgian Prospective, Non-randomized Multi-center, Controlled Physician-initiated Trial: Evaluation of the Safety and Efficacy of the ClearLumen II Peripheral Thrombectomy System Recanalization of Acute and Subacute Thrombotic Femoropopliteal Occlusions
Enrollment Status: Completed
Publish Date: October 16, 2024
Intervention Type: Device
Study Phase: Not Applicable
Belgo-France Physician-initiated Trial Investigating the BeGraft Peripheral Plus Stent Graft System for the Treatment of Iliac Lesions (TASC A, B, C and D)
Belgo-France Physician-initiated Trial Investigating the BeGraft Peripheral Plus Stent Graft System for the Treatment of Iliac Lesions (TASC A, B, C and D)
Enrollment Status: Active_not_recruiting
Publish Date: October 16, 2024
Intervention Type: Device
Study Phase: Not Applicable
View 9 Less Clinical Trials

32 Total Publications

Head-to-head comparison of two paclitaxel-coated balloons for femoropopliteal lesions: 3-year results from the BIOPACT RCT.
Head-to-head comparison of two paclitaxel-coated balloons for femoropopliteal lesions: 3-year results from the BIOPACT RCT.
Journal: The Journal of cardiovascular surgery
Published: December 23, 2025

Frequently Asked Questions about Lieven Maene

Is Lieven Maene a top-rated expert for Peripheral Artery Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Lieven Maene is classified as an Distinguished expert for Peripheral Artery Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Lieven Maene participate in research or clinical trials?

Yes. Lieven Maene has published 32 articles and abstracts on conditions like Peripheral Artery Disease. You can view a list of Lieven Maene's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Maene's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile